Related Experiment Video

Updated: Sep 22, 2025

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.7K

The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis

Zixia Huang1, Mingyue Wu1, Lijin Zeng2

  • 1Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

Cardiology Research and Practice
|May 23, 2022
PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) may protect against cardiovascular disease (CVD) by improving endothelial function. Nrf2 combats oxidative stress and mitochondrial damage, potentially delaying atherosclerosis and offering new therapeutic avenues.

Area of Science:

  • Cardiovascular research
  • Molecular biology
  • Cellular mechanisms

Background:

  • Cardiovascular disease (CVD) is a leading cause of death globally and in China.
  • Atherosclerosis underlies major CVDs like heart attack and stroke.
  • Endothelial dysfunction, oxidative stress, and mitochondrial damage are key factors in atherosclerosis.

Purpose of the Study:

  • To investigate the mechanisms by which Nuclear factor erythroid 2-related factor 2 (Nrf2) influences endothelial cell function.
  • To explore Nrf2's role in mitigating atherosclerosis and its potential as a therapeutic target for CVD.

Main Methods:

  • Review of current research on Nrf2, oxidative stress, mitochondrial function, and endothelial cells.
  • Analysis of Nrf2's antioxidant and cytoprotective pathways.
  • Examination of Nrf2's impact on endothelial dysfunction in the context of atherosclerosis.

Main Results:

  • Nrf2 activation demonstrates protective effects against oxidative stress and mitochondrial damage in endothelial cells.
  • Nrf2 signaling appears to improve endothelial function, thereby inhibiting the development of atherosclerosis.
  • Evidence suggests Nrf2 plays a critical role in cardiovascular health.

Conclusions:

  • Nrf2 is a promising therapeutic target for cardiovascular disease.
  • Understanding Nrf2's mechanisms offers potential for novel CVD treatments.
  • Targeting Nrf2 could combat atherosclerosis by enhancing endothelial function and reducing oxidative stress.

More Related Videos

Preparation of Naringenin Solution for In Vivo Application08:18

Preparation of Naringenin Solution for In Vivo Application

Published on: August 10, 2021

3.4K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.8K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
50
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
107
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
74